(AGENPARL) – Mon 09 February 2026 Screenshot (124).png
 Read the news also in:
 Machine-translated versions are also available in all EU languages on the EFSA website.
EFSA’s scientists have established a provisional safe intake level for adults for cannabidiol (CBD) as a novel food but highlighted persistent data gaps.
Provisional safe level
When the available evidence is incomplete, EFSA’s scientists may set provisional safe intake levels. The level includes an added safety factor – or uncertainty factor – to protect health despite uncertainties in the available data.
EFSA’s scientists will review the provisional safe level when the required toxicological and/or human data become available, either from applicants or in published research.
Food supplements
The provisional safe level applies solely to food supplement formulations containing CBD with a purity of at least 98%, without nanoparticles, and for which the production process is deemed safe and genotoxicity has been excluded.
For individuals under 25 years old, pregnant and lactating women, and those on medication, EFSA’s scientists concluded that the safety of CBD cannot be established.
Data gaps
Applicants are responsible for filling data gaps. To support applicants in providing the missing information, EFSA held an information session in June 2022 and is now planning a follow-up webinar to take place in April.
Next steps
EFSA will proceed with the risk assessment of each CBD novel food application based on the data made available by each applicant.
Links to science
————————————————————
For inquiries please contact:
EFSA Media Relations Office
______________________
European Food Safety Authority, Via Carlo Magno 1/a, Parma, . 43126 Italy